CeeTox’s proprietary in Vitro screens are utilized by bio/pharmaceutical, chemical, nutraceutical and government entitities, and continually demonstrates the value of its technology to their clients’ discovery efforts.
CeeTox had an opportunity to work with Cytorex’s proprietary compound Cytoreg®, a great innovation in the fight against cancer. The testing performed by CeeTox, in rat hepatoma (liver cancer), normal hepatocytes (liver), and normal kidney cells, indicated a distinctive cytotoxic activity of Cytoreg® in cancer cells. The CeeTox results were included in the preclinical data package evaluated by the National Cancer Institute, and allowed Cytorex to reach a collaboration agreement with the NCI, to develop the Cytoreg® program as a potential treatment for glioblastoma multiforme (brain cancer).
“We began collaborating with CeeTox in 2006. Incorporating CeeTox’s technology into our drug discovery efforts is helping us to select the best compounds for clinical testing from our discovery efforts, as well as select initial doses for evaluation in clinical trials.”
Technology Manager, Program Management and Strategic Planning, Vertex Pharmaceuticals, Inc.
CeeTox works closely with scientists and technology partners to advance new chemical entities for the drug development market.
Argutus Medical Ltd. was formed in July 2008 as a spin out company from Biotrin Internation Ltd to give enhanced focus to expanding its portfolio of test kits. Argutus Medical is a world leader in developing and manufacturing novel organ injury tests for use in the detection of early, acute damage to the kidney, liver and pancreas. These eay-to-use microtitre plate assay kits have particular use in preclinical pharmaceutical R&D, Human phase I, II and III clinical trials, and hospital diagnostics. CeeTox is a preferred reference laboratory for Argutus’ novel acute kidney injury (AKI) biomarker panel.
Round Rock, TX
Antimicrobial Test Laboratories is a full service contract research facility specializing in the testing of antimicrobial agents including disinfectants, sanitizers, and preserved products. President Benjamin Tanner holds a Ph.D. in Microbiology and Immunology from the University of Arizona, where he studied infectious disease transmission with Dr. Charles Gerba. Dr. Tanner is the author of the book “Legal Aspects of Infectious Diseases.” He has worked extensively with industry, academia, and government. Before launching Antimicrobial Test Labs in 2006, Dr. Tanner enjoyed years as a microbiologist with the Clorox Company.
Cosmetic Test Labs is an independent specialty contract laboratory created to give makers of personal care products a testing facility they can depend on. Cosmetic Test Labs offers a full array of testing services, including bacterial and fungal contamination testing, preservative efficacy testing, shelf life and stability testing, and toxicology.